Values First Advisors, Inc.

SEC CIK: 0001913608
Latest filing: Aug 4, 2026

SEC filings (opens in a new tab)

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Values First Advisors, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overview All 13F holders of RARE Full Q2 2026 holdings

Shares (Q4 2024): 0; Sold out in Q4 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2023

Holdings of RARE by Values First Advisors, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2024	0	$0	0.0%	−1,010−100.0%	Sold out	Holders
Q3 2024	1,010	$56.1K	<0.1%	+1,010	New	Holders
Q2 2023	0	$0	0.0%	−1,489−100.0%	Sold out	Holders
Q1 2023	1,489	$59.7K	<0.1%	+1,489	New	Holders